|
|||||
|
|
| The Forefront for Novel Therapeutic Agents Based on the Pathophysiology of Lower Urinary Tract Dysfunction: Bladder Selectivity Based on In Vivo Drug–Receptor Binding Characteristics of Antimuscarinic Agents for Treatment of Overactive Bladder | |
| 摘 要： | |
| 收稿时间： | 2009-08-04 |
| 本文献已被 ScienceDirect 等数据库收录！ | |